Yankees Rumors

Rays Acquire Marshall Toole As PTBNL From José Caballero Trade

By Darragh McDonald | September 17, 2025 at 3:25pm CDT

Outfield prospect Marshall Toole is heading from the Yankees to the Rays, according to announcements from both clubs. He is the player to be named later from the deadline deal which sent José Caballero to the Yankees and Everson Pereira to the Rays. Toole wasn’t on the Yankees’ 40-man roster and therefore doesn’t need to take up a spot with the Rays.

Toole, 22, was a 15th-round pick of the Yankees in last year’s draft. Since that selection, he has played in 113 Single-A games, stepping to the plate 441 times. His 20.6% strikeout rate thus far is decent while his 15.2% walk rate is quite strong. His .298/.413/.462 batting line translates to a 148 wRC+. He has also stolen 52 bases in 60 tries.

Those are obviously some nice numbers but there are some caveats. That offensive production includes just six home runs and is being propped up by a massive .380 batting average on balls in play. Toole is also a bit old for his level and will face stiffer competition as he moves up the ladder. He’s not currently listed as one of the top 30 prospect in the Yankee system by Baseball America nor MLB Pipeline.

Put all together and it feels like a very Rays-style pickup, a player without a huge profile but one with some interesting tools. The club has turned a few such players into decent big league contributors over the years. Perhaps the same could be true of Toole but he’s likely a few years away since he still has to climb a few more rungs of the minor league ladder. He won’t be eligible for the Rule 5 draft until December of 2027.

Photo courtesy of Kim Klement Neitzel, Imagn Images

Cashman: Yankees “Believe In” Anthony Volpe Despite “Tough Stretch”

By Mark Polishuk | September 14, 2025 at 5:08pm CDT

Anthony Volpe’s underwhelming season has made the shortstop a topic of controversy in the Bronx, and more attention was generated this week when it was revealed that Volpe has been playing with a small tear in his left shoulder labrum since May 3. Trying to play through this shoulder problem has clearly impacted Volpe’s performance — not only has he hit .197/.248/.378 in 418 plate appearances since suffering the injury, Volpe’s formerly excellent defense has drastically fallen off.

Speaking with ESPN’s Jorge Castillo and other reporters on Friday, Yankees GM Brian Cashman noted Volpe’s “tough stretch” and said that “this isn’t the season we expected or he expected.” That said, Cashman gave a vote of confidence to Volpe, saying that the 2025 season “doesn’t change our viewpoint of what he’s capable of,” and that he is still the Yankees’ choice at shortstop going forward.

“He’s someone that we can count on and we believe in….I think he’s a really talented guy and I think he has a chance to be a positive impact, obviously,” Cashman said.

Volpe was hitting significantly better (.239/.333/.453) in his first 135 plate appearances of the season pre-injury, so it could be that his labrum tear prevented a potential breakout year. Still, Volpe’s full-season numbers aren’t far off the .228/.288/.373 slash line he posted over 1290 PA in his first two Major League seasons, so it isn’t as if struggles at the plate are a new problem for the 24-year-old.

Outsized expectations have followed Volpe ever since his emergence as one of baseball’s top prospects, and the Yankees’ decision to debut him as their Opening Day shortstop in 2023. While the team itself has always been quick to downplay the “next Derek Jeter” hype, the Yankees’ immediate installation of Volpe in an everyday role has stood in stark contrast to the club’s more infrequent usage of most other top minor leaguers in recent years. If anything, Volpe’s critics are sure to argue that Cashman’s continued confidence in Volpe is part of the problem, and that the Yankees should be more open to upgrading at shortstop.

While Cashman has made some rather blunt critiques of other New York players in the past, it only makes sense for the GM to continue his public support of Volpe, and there isn’t any reason to yet suspect that the Yankees aren’t viewing Volpe’s rough year as anything but a by-product of his shoulder injury. Since Volpe is only entering arbitration eligibility this coming offseason, his three remaining years of pretty inexpensive team control make him an intriguing asset on a team loaded with big salaries and a hefty luxury tax bill. If Volpe is able to get healthy and break out as, in Cashman’s words, “a quality, above-average regular shortstop in the game,” that’s a major boost for the Yankees on every front.

Still, finding another inexpensive shortstop candidate could change the equation, and one such player may have already been found in Jose Caballero. Acquired from the Rays at the trade deadline, Caballero has hit .263/.358/.439 in 68 PA in the pinstripes, which far and away represents the best offensive stretch of his three MLB seasons. The utilityman has also pitched in at both corner outfield slots, second base, and third base, but most of Caballero’s time has come at shortstop in the wake of Volpe’s increased missed time.

Volpe hasn’t played since Tuesday after receiving a cortisone shot in his ailing shoulder, paving the way for Caballero to step into regular shortstop duty. Boone told Castillo and company that “we’ll see” about who plays shortstop when Volpe is ready to return, which hints that the Yankees could be considering a timeshare at the position.

The longer-term issue of Volpe’s health is also a lingering question. Cashman said more will be known once Volpe receives more tests, and while the GM “wouldn’t rule…out” an offseason surgery, “as of right now, there’s no surgery recommended. There’s not even an IL recommended.” Should Volpe indeed end up going under the knife, he’d very likely miss some time and perhaps an extended amount of the 2026 season, leaving the Yankees in need of another shortstop.

Anthony Volpe Playing Through Partial Labrum Tear

By Darragh McDonald | September 11, 2025 at 11:55pm CDT

Anthony Volpe has been the Yankees’ regular shortstop for close to three years now. Lately, he has struggled enough that José Caballero has taken some playing time. It’s possible that health is playing a role in Volpe’s downturn. He injured his left shoulder back in early May. Today, Joel Sherman of The New York Post reports that the shoulder discomfort has lingered since then and Volpe received a cortisone shot in that shoulder yesterday.

Yankees manager Aaron Boone spoke to the media before tonight’s game and provided more details, per Brendan Kuty of The Athletic and Bryan Hoch of MLB.com. Boone confirmed the report of the cortisone shot and said Volpe has a small labrum tear in his shoulder. When the injury was discovered in May, they believed it was an old injury that he could play through. He has since aggravated it multiple times, including on Sunday. He also had a cortisone shot during the All-Star break, per Kuty. The Yanks don’t believe he needs an IL stint now. He will have another MRI after the season.

At the time of that injury, Volpe said he heard a “pop” in his shoulder but quickly felt better. “It happened quick and it was scary, but after that, I felt OK and I felt like I had my strength,” Volpe said at the time. “I’ve never really had anything else pop or dislocate or anything like that, so I have nothing to compare it to.”

Greg Joyce of The New York Post writes that the Yankees have consistently downplayed the shoulder injury even though Volpe is usually wrapped up in ice after most games. Just yesterday, Boone brushed off the problem, per Chris Kirschner of The Athletic.

“I think early on after that, maybe a little bit,” the skipper said, when asked if Volpe’s shoulder has been impacting his performance. “I think it’s something that’s also improved over the course of the year. I feel like, even lately, it’s been in as good of a place as it’s been. I don’t necessarily think that’s the case, but he’s also a very tough kid and a gamer. I don’t think so, but I guess shouldn’t rule it out.”

As noted by Sherman, there’s a stark contrast between Volpe’s pre- and post-injury numbers. On May 4th, he had a .233/.326/.442 batting line. That translated to a 114 wRC+, indicating he was 14% better than league average at that point in the season. Since then, he has a .197/.248/.378 line and 70 wRC+.

It’s also possible that the injury is impacting Volpe defensively. He was credited with 15 Defensive Runs Saved in 2023 and six last year but is at just one here in 2025. Outs Above Average is even more notable. That metric gave Volpe a +1 grade in 2023 and +14 last year but has dropped him all the way to -9 here in 2025. Volpe made eight throwing errors in 2023 and nine last year but already has 13 in 2025, in a smaller sample of playing time.

Despite the declining numbers, Boone has stuck by Volpe. A couple of weeks ago, the skipper said that he still considered Volpe to be the club’s shortstop while Caballero was considered a “10th man” who could bounce around to various positions in a utility capacity.

More recently, it’s possible there’s been a shift. Caballero has started in place of Volpe in two of the past five games. It’s possible the cortisone shot leads to Volpe missing some more time, as players usually require a few days’ rest after receiving such injections.

On the one hand, it’s somewhat encouraging that Volpe’s struggles have a possible explanation. On the other hand, it’s a less than ideal situation at this time of year when every game is meaningful. The Yanks currently hold a Wild Card spot but they are in a tight battle with clubs like the Red Sox, Mariners, Rangers, Guardians, Royals and Rays. The Yanks are also surely hoping to chase down the Blue Jays for the division lead, currently trailing by just three games.

Sending Volpe to the injured list or simply sitting him for a few games could perhaps help his shoulder woes a bit but that would leave the club a bit thinner at shortstop as they play meaningful games. There would also be the risk of Volpe getting rusty after a layoff and not having time to get into a better groove.

For now, it seems Caballero could benefit from a bit more playing time. He has a solid .239/.345/.413 line since being acquired at the deadline but he has a career .226/.313/.335 slash and 89 wRC+. Even if his hitting is subpar, his glovework is good and he’s one of the top base stealers in the majors. If Volpe does require a stint on the IL, the Yanks could perhaps recall Braden Shewmake to serve as a glove-first backup to Caballero.

Photo courtesy of John Jones, Imagn Images

Anthony Rizzo Retires

By Steve Adams and Darragh McDonald | September 10, 2025 at 11:59pm CDT

The Cubs have announced that Anthony Rizzo will retire as a Cub and will be honored this Saturday at Wrigley Field as the club hosts the Rays. He will also serve as an ambassador for the organization. Jesse Rogers of ESPN was among those to relay the news.

Rizzo, now 36, was part of a few different organizations in his career but will always be primarily known as a Cub. He spent the bulk of his career, including essentially all of his prime, in Chicago. That stretch saw him emerge as a core piece as the team became a regular contender in the last half of the previous decade. The highlight came in 2016, when the Cubs finally won the World Series, breaking a 108-year drought.

There was talk of a potential dynasty on Chicago’s north side after that year, as that young core of Rizzo, Kris Bryant, Javier Baez, Willson Contreras and Jorge Soler was controllable, affordable and formidable. The top of the rotation appeared set for years, with Jon Lester, Jake Arrieta and Kyle Hendricks all squarely in their primes and signed/controlled long-term. The Cubs indeed were competitive on a yearly basis for the remainder of the decade, but they fell to the Dodgers in the 2017 NLCS and haven’t advanced beyond the Wild Card round of postseason play since.

Before that legendary run, Rizzo had to pass through a few other places first. He was drafted by the Red Sox out of high school back in 2007. After a few years in Boston’s minor league system, he was flipped to the Padres as one of the players in the December 2010 deal that sent Adrián González to the Sox.

Rizzo got to make his big league debut with the Friars in 2011 but didn’t hit the ground running. He stepped to the plate 153 times over 49 games but struck out 30.1% of the time and produced a .141/.281/.242 line.

Going into 2012, the Padres decided to go in a different direction. They sent Mat Latos to the Reds for four players, one of whom was Yonder Alonso. With Alonso set to cover first base in San Diego, they then sent Rizzo and right-hander Zach Cates to the Cubs for righty Andrew Cashner and outfielder Kyung-Min Na.

That gambit clearly didn’t pan out for San Diego. While Cashner had some modest success with the Padres, Alonso never found his power stroke at Petco Park and wound up delivering average offense over parts of four seasons. Yasmani Grandal, also acquired in that swap, struggled in San Diego before being sent to the Dodgers as part of the Matt Kemp trade.

Meanwhile, as all that played out, Rizzo broke out as one of the top first basemen in Major League Baseball. In parts of 10 seasons with the Cubs from 2012-21, Rizzo batted a combined .272/.372/.489 with 242 home runs. He made three All-Star teams, won four Gold Gloves, won a Silver Slugger and garnered MVP votes in five consecutive seasons — including a pair of consecutive fourth-place finishes in 2015-16, when he posted a combined .285/.386/.528 batting line (145 wRC+) and belted 63 home runs (31 in ’15, 32 in ’16). Rizzo struggled in the 2016 NLDS but erupted in both the NLCS and World Series, belting three homers and five doubles with an OPS north of 1.000 between those two series.

As that Cubs core continued to stall out over the years, however, the front office eventually determined there was a need for change. Rizzo, Bryant and Baez were all traded in the summer of 2021 — Baez to the Mets, Bryant to the Giants and Rizzo to the Yankees. Rizzo hit well for the Yankees down the stretch and stepped into a key leadership role, all of which convinced the team to re-sign him to a two-year deal with an option for a third season.

Rizzo went on to spend the final three full seasons of his career in the Bronx, hitting well in 2022 before slipping to about average in 2023 and struggling through injuries in 2024. His time in New York wasn’t nearly as productive, but he logged an overall .234/.326/.409 line as a Yankee and popped 32 home runs in his first full season in pinstripes.

All told, Rizzo’s excellent career will wrap up with a lifetime .261/.361/.467 batting line. He hit 303 home runs in the majors, scored 922 runs, plated 965 runs and even swiped 72 bases. Rizzo is one of just 164 players in major league history to reach 300 career home runs. His 338 doubles rank 352nd all-time, tied with Brady Anderson, Matt Williams, Robin Ventura and the aforementioned Kemp.

Rizzo also tallied 241 postseason plate appearances, and while his .225/.328/.397 line doesn’t stand up to his regular-season excellence, that’s skewed by a brutal showing in the 2015 playoffs. Starting with that NLCS breakout in ’16, Rizzo hit .260/.367/.455 in his final 180 turns at the plate in the playoffs.

Through an early-career extension with the Cubs and a free-agent deal to re-sign with the Yankees in the 2021-22 offseason, Rizzo earned more than $127MM in salary over parts of 14 seasons. FanGraphs valued his career at 35.9 wins above replacement, while Baseball-Reference is even more bullish at 40.4 WAR. Rizzo isn’t likely to be Cooperstown-bound, but he’ll be remembered as a cornerstone piece in an iconic era of Cubs franchise lore and a solid veteran pickup who helped drive some competitive Yankees clubs. Best wishes to Rizzo and his family in whatever the next chapter holds.

AL East Notes: Abreu, Kremer, Sugano, Goldschmidt

By Mark Polishuk | September 7, 2025 at 2:19pm CDT

Wilyer Abreu was (retroactively) placed on the 10-day injured list on August 18 due to a right calf strain, and some eyebrows were raised last Sunday when both Abreu and Red Sox manager Alex Cora didn’t have any sort of timeline in place for the outfielder’s return, other than Abreu stressing that he wanted to “be ready for the playoffs.” Some literal steps in the right direction were taken this weekend when Cora told MassLive.com’s Chris Cotillo and other reporters that Abreu took part in running activities on both Friday and Saturday.

Cora described the drills as “the start of the progression,” and noted that Abreu “wasn’t at full speed.” The skipper didn’t have any more details about when Abreu could be tapped for a minor league rehab assignment or an activation from the IL. While naturally the Red Sox won’t rush Abreu for fear of re-aggravating his injury, there is some increased urgency to bolster the outfield now that Roman Anthony’s regular season has possibly been ended by an oblique strain. What was once an overcrowded outfield picture in Boston has been thinned out by the loss of two regulars, leaving the Sox with a Rob Refsnyder/Nate Eaton timeshare in right field since Anthony’s IL placement.

Aaron Judge Returns To Right Field

By Anthony Franco | September 5, 2025 at 4:58pm CDT

Aaron Judge returns to the outfield as the Yankees begin a pivotal series against the Blue Jays. He’s making his first start in right field since being diagnosed with a flexor strain on July 26. That sent Judge to the injured list for a minimal 10 days. He spent the next month as a full-time designated hitter because the forearm issue made it difficult for him to throw.

The Yankees will ease Judge back to action. Manager Aaron Boone told reporters (including Bryan Hoch of MLB.com) that the two-time MVP will not play defense every day. Boone suggested Judge will divide right field playing time with Giancarlo Stanton. They’ll happily take whatever opportunities they can to keep Stanton out of the outfield. He’s in the DH spot tonight against Kevin Gausman.

Jazz Chisholm Jr. is also playing the series opener. He’s hitting fifth and back at second base. Chisholm departed last night’s win over the Astros with contusions on both knees. He was hobbled during the game but confirmed afterwards that testing ruled out any ligament damage (relayed by Brendan Kuty of The Athletic). He’s back tonight for one of New York’s biggest sets of the year.

The Jays have a three-game cushion in the AL East. The Yankees are half a game up on the Red Sox for second place and the American League’s top Wild Card position. All three teams have very strong odds of making the postseason. They’re all in play for the division, which would likely come with a first-round bye. Toronto, New York and Boston each have a better record than the AL West-leading Astros, so the East winner should secure one of the top two seeds. The Jays are a half-game ahead of the Tigers for the best record in the American League.

Poll: Who Will Win The AL East?

By Nick Deeds | September 2, 2025 at 11:39am CDT

We’re into the final weeks of the season now, but a handful of postseason races are still up for grabs. Perhaps the most competitive division at this point is the AL East, which is the only division where three teams still have at least a 10% chance of taking home the crown according to Fangraphs. Who will ultimately emerge victorious? Here’s a look at each of the three teams, listed in order of their winning percentage entering play today:

Toronto Blue Jays (79-59)

The Jays took the lead in the division on July 3 and haven’t relinquished it since. It’s not hard to see why they’ve been successful. Vladimir Guerrero Jr. isn’t having the sort of superlative, MVP-level campaign he posted in 2024 but remains an anchor for the lineup with 21 homers, 30 doubles, and a .383 on-base percentage. George Springer has enjoyed a resurgent season at the age of 35, slashing an outstanding .300/.391/.533 in 116 games. Bo Bichette (130 wRC+) is back to his normal self after last year’s injury-ruined season. Alejandro Kirk (118 wRC+) is making good on his extension with the club by putting up his best season since 2022. Daulton Varsho has 16 homers in 49 games despite dealing with injuries, and even less-established hitters like Nathan Lukes, Addison Barger, and Davis Schneider have put up strong numbers at the dish.

While so much has gone right for the Jays on offense, it must be noted that things haven’t gone as well when it comes to pitching. Kevin Gausman looks like the steady and playoff-caliber veteran he’s been for years now, but the rest of the rotation comes with questions. Toronto was reaping the benefits of Max Scherzer turning back the clock for a few weeks, but the future Hall of Famer just delivered back-to-back clunkers against the Twins and Brewers. Eric Lauer was pitching well but was sent to the bullpen after posting a 5.30 ERA in August. Chris Bassitt and Jose Berrios are stable veterans, but they fit better at the back of the rotation than starting Games 2 and 3 of a playoff series. The bullpen has struggled somewhat as well, with closer Jeff Hoffman scuffling to a 5.02 ERA on the season and a 5.32 ERA since the start of July. Those pitching woes have led the Jays’ lead in the division to slip from five games a week ago to 2.5 games. Will they be able to stop the bleeding and secure a division title?

New York Yankees (76-61)

Just a couple of weeks ago, the Bronx Bombers looked to be in a more dire position after losing five straight to the Marlins and Rangers before dropping three games in a row to the Red Sox. They rebounded from those losses to Boston by picking up the final game of that series, however, and that win started a seven-game streak that only just ended with a close loss to the White Sox over the weekend. While nice performances from players like Trent Grisham, Ben Rice, Cody Bellinger, and Jazz Chisholm Jr. have been helpful for the Yanks this season, their success can be overwhelmingly attributed to Aaron Judge.

The reigning AL MVP has put together another season for the ages (196 wRC+), and it’s largely thanks to him that the club has been able to hang in the postseason race despite a disappointing season from Anthony Volpe and Paul Goldschmidt’s second-half struggles. Of course, Judge has been recovering from a flexor strain that’s seemingly impacted him at the plate and kept him from playing the field. That’s pushed Giancarlo Stanton’s strong bat out of the lineup on some days and forced his subpar glove into the outfield on the rest. A leaky bullpen hasn’t helped, though the starting rotation is looking better now that Max Fried appears to be getting back on track after a rough patch. One other thing working in New York’s favor is the schedule; they’ll face the last-place Orioles and White Sox in their final 10 games of the season.

Boston Red Sox (77-62)

The Red Sox have worked their way back from the malaise they faced towards the end of the Rafael Devers era to make themselves legitimate playoff contenders. Unlike the other two AL East clubs, it’s been the pitching leading the way. Garrett Crochet is in the conversation for best pitcher in baseball this year, and both Brayan Bello and Lucas Giolito have looked the part of playoff starters. It’s arguably been a career year for veteran closer Aroldis Chapman, and Garrett Whitlock has excelled in a setup role. Top prospect Payton Tolle has been called up for the stretch.

While Boston’s pitching staff is impressive, they’re held back a bit by an offense that doesn’t quite measure up. Roman Anthony already looks like a star, but the rest of the lineup has lacked consistency. Alex Bregman is slumping since the start of August, Wilyer Abreu is on the injured list, and Ceddanne Rafaela has struggled badly since the All-Star break. Trevor Story started slow but has been great since June. Romy Gonzalez has tattooed lefties but been sub-par versus righties. Boston’s 24-17 record since the All-Star break is still encouraging though, and if Abreu comes back healthy and/or Bregman turns things around, the lineup would look more formidable.

Each of the three remaining contenders for the AL East title have one series against each other left in September. Who do MLBTR readers think will come out on top? Will the Blue Jays hold on despite their pitching woes? Can Judge lead the Yankees back to the top of the division? Or will the Red Sox offense turn things around to support their excellent pitching? Have your say in the poll below:

Poll: Will Anyone Get To 60 Home Runs This Year?

By Nick Deeds | September 1, 2025 at 12:58pm CDT

It’s been a great year for power hitters in MLB, as five different players slugged their 40th home run of the season before the end of August. It’s not often that so many hitters enter September with a realistic shot at the lofty threshold of 60 home runs in a season. It’s a feat that’s only been accomplished nine times, and the combination of Sammy Sosa and Mark McGwire account for five of those nine 60-homer seasons. Of course, it’s an incredibly rare feat for a reason, and many promising campaigns fall short in the season’s final month. 12 seasons with between 56 and 59 home runs have been logged throughout MLB history, after all.

Will this year’s biggest power threats join that club of also-ran seasons, or will we see the tenth 60-homer season in MLB history come to fruition this year? Here’s a look at each of the top home run hitters from this season and their chances of reaching that illustrious 60-homer plateau, in order of their current home run totals for 2025:

Cal Raleigh

While everyone else on this list hit their 40th homer of the season in August, Raleigh’s 40th home run was actually slugged on July 26. The Mariners’ catcher has had a historic season this year, setting the all-time single season home run record for a catcher while sitting just four behind Mickey Mantle for the all-time single season record for home runs by a switch hitter. With 50 homers tallied so far this year, it’s hard not to see why Raleigh could have a very real shot at hitting 60 home runs this season. He’s hit at least ten homers in three of the season’s five months so far, and has never hit less than eight in a month this year. With that being said, it’s also worth noting that Raleigh has slowed down a bit in the second half of the season. In 40 games since the All-Star break, Raleigh has posted just a 112 wRC+ with 12 home runs. With just 25 games left to play on the Mariners’ schedule, he’ll need to pick up the pace if he’s going to reach 60 homers this year.

Kyle Schwarber

Schwarber is just one homer back of Raleigh in the race for the MLB home run lead after an incredible four-home run performance on August 28. Schwarber has long been one of the game’s premiere power threats and, like Raleigh, has hit at least 10 homers in three of this season’s five months so far. He’ll need to hit 11 in 25 September games in order to reach 60 homers, but one thing working in his favor is that he’s saved most of his power for the second half this year. He’s hit 12 home runs in both July and August, so if he can put up just one more month like the last two, he’ll get there. Of course, a player slugging .655 over his past 52 games also runs the risk of getting pitched around, which could damage Schwarber’s chances of making it to 60. One thing that could work in Schwarber’s favor is his home ballpark, as Statcast considers Citizens Bank Park to be the fifth-most homer friendly stadium in the majors this year.

Shohei Ohtani

With three MVP awards in the past four years, no one should put anything past baseball’s two-way superstar. Ohtani became the first player to go 50-50 last season, and with 54 homers tied with Mantle (and seven other seasons) at 22nd on the single-season home run leaderboard. With 45 home runs headed into September, he has an outside shot at not only breaking that personal record, but getting a coveted 60-homer season. 15 home runs in a single month is a tall order for any player, but Ohtani did exactly that back in May when he crushed 15 long balls in 27 games. The Dodgers have two fewer games than that in September, but Ohtani will benefit from playing his home games at Dodger Stadium, which is far and away the most homer-friendly ballpark in the majors this year per Statcast.

Aaron Judge

Aaron Judge hit his 43rd home run of the season yesterday, and that makes it a tall order for him to reach 60 homers this season. With that being said, onlookers around the game should know better than to doubt the hulking slugger’s offensive abilities at this point, with MVP wins in two of the last three seasons and a completely absurd 202 wRC+ since the start of the 2022 season. Judge is also, of course, the only active player who’s already a member of the 60 home run club after bashing 62 long balls to take the AL home run record from Roger Maris during his 2022 AL MVP campaign. Judge finished just short with 58 home runs last year, but perhaps this year will be different. In order to reach 60 on the season, Judge will need to make a different kind of history: as noted by Thomas Harrigan of MLB.com last year, the record for home runs hit in September (and October, in seasons where it hosts regular season games) belongs jointly to Albert Belle and Babe Ruth. Judge would need to at least tie that duo’s 17 homers in the final month of the year in order to crack 60 long balls this year.

What do MLBTR readers think? Will the league enjoy a 60-homer campaign for the second time in four years this season? And if so, who is most likely to pull it off? Have your say in the polls below:

Kenta Maeda Plans To Pitch In Japan In 2026

By Mark Polishuk | August 31, 2025 at 11:08pm CDT

In an appearance on TV Tokyo’s “Sports Real Live” show (Japanese language link from Yahoo Japan), Kenta Maeda said that he is leaving North American baseball behind at the conclusion of the 2025 season. Maeda revealed that he initially made his decision after signing his two-year, $24MM deal with the Tigers that that would be his final contract with a Major League team, and he is hoping to continue his career in Japan with a Nippon Professional Baseball club in 2026.

Maeda (who turns 38 in April) began his pro career with eight seasons with the Hiroshima Carp before being posted for MLB clubs, and signing an incentive-heavy eight-year, $25MM deal with the Dodgers back in January 2016. Maeda’s stint in North America has seen him suit up in nine Major League seasons, with the 2022 campaign missed entirely since he was recovering from a Tommy John surgery.

After struggling badly in the first year of his Tigers contract, a move to the bullpen didn’t change Maeda’s fortunes this year, and Detroit released the right-hander in early May. He then joined the Cubs on a minor league contract before being released in early August, quickly landing with the Yankees on another minors deal. Over 76 1/3 Triple-A innings this season, Maeda hasn’t shown any of his old form, posting a 6.25 ERA for New York and Chicago’s top affiliates.

During the TV Tokyo interview, Maeda said his family has been living in Japan during his year in the minors, in order to have some stability while Maeda has now bounced around to multiple teams. His recent on-field results (or lack thereof) had no bearing on his decision, as Maeda stated that he would’ve returned to Japan after 2025 if he’d been a 20-game winner at the big league level.

Since it doesn’t look like the Yankees will be calling Maeda up in September, his MLB resume could be closed after 226 games (172 of them starts) with the Tigers, Twins, and Dodgers over parts of nine seasons. Maeda has a 4.20 ERA, 25.8% strikeout rate, and 7.8% walk rate over 986 2/3 career innings in the regular season, as well as a 3.24 ERA across 41 2/3 career postseason frames with Minnesota and Los Angeles.

Though his final act in Detroit didn’t go well, Maeda was generally a very effective pitcher in the majors. He had a 3.87 ERA during 589 innings in L.A., with the Dodgers using Maeda both as a starter and as a reliever, though Maeda made it known that he preferred rotation work. A trade to the Twins prior to the 2020 season gave Maeda a full-fledged starting job, and he responded with a runner-up finish in AL Cy Young Award voting, posting a 2.70 ERA in 66 2/3 innings during the pandemic-shortened season. He wasn’t as effective during a 2021 campaign that was cut short by his Tommy John procedure, though Maeda returned in solid form (4.23 ERA in 104 1/3 IP) for Minnesota’s AL Central-winning team in 2023.

Jonathan Loáisiga Done For The Year

By Darragh McDonald | August 28, 2025 at 5:35pm CDT

Yankees right-hander Jonathan Loáisiga has a flexor strain and won’t return this year. However, he is unlikely to require surgery, which perhaps bodes well for next year. Manager Aaron Boone provided the news to reporters including Chris Kirschner of The Athletic and Greg Joyce of The New York Post.

Loáisiga, 30, is a talented pitcher but he has often been held back by injuries. In 2023, he underwent surgery to remove a bone spur from his elbow and only pitched 17 2/3 innings that year. In April of 2024, he required internal brace surgery on the ulnar collateral ligament in his throwing elbow.

He reached free agency and the Yankees decided to sign him for 2025, even though he was still recovering from that surgery at the time. Before all the injuries popped up, Loáisiga had put up some good numbers. Over 2020 and 2021, for instance, he logged 93 2/3 innings with a 2.50 earned run average, 23.8% strikeout rate, 6% walk rate and 58.4% ground ball rate.

The Yanks were surely hoping that a clean bill of health could get him back to that level but it didn’t play out that way. He was reinstated from the injured list in mid-May but landed back on the IL due to mid-back tightness. He started a rehab assignment shortly thereafter but then suffered the flexor strain which has now ended his season. Around those injuries, he gave the Yankees 29 2/3 innings with a 4.25 ERA, 18.5% strikeout rate, 7.4% walk rate and 50.5% ground ball rate.

The Yankees bolstered their bullpen ahead of the deadline by trading for David Bednar and Camilo Doval, adding those two to a group that already included Devin Williams, Luke Weaver and others. They recently welcomed Fernando Cruz back from his own IL stint. The relief corps has a 4.88 ERA in August but there’s lots of talent in there and they have a chance at righting the ship down the stretch and into the postseason. Getting a healthy Loáisiga in there could have helped but that won’t happen now.

The Yankees will have to make a decision about next year. Loáisiga’s $5MM deal came with a $4.5MM salary and $500K signing bonus, plus a $5MM club option for 2026 with no buyout. They were willing to place a $5MM bet on him last offseason but it’s possible his subpar performance this year pushed them away from doing so again. This injury presumably makes it even less likely they trigger the option. But they clearly like the player and he’s unlikely to require surgery, so perhaps they could re-sign him at a different price point.

Boone also relayed, per Kirschner, an update on lefty Ryan Yarbrough. The southpaw will likely be working out of the bullpen when he comes off the IL. He gave the Yanks some good results in a swing role earlier this year, making eight starts and eight relief appearances with a 3.90 ERA. Unfortunately, a right oblique strain put him on the IL in mid-June.

While Yarbrough has been away, Luis Gil returned from his own IL stint to retake a spot in the rotation. Also, Cam Schlittler came up from the minors and has been really good through his first eight starts. The rotation now features those two alongside Max Fried, Carlos Rodón and Will Warren.

Yarbrough has been rehabbing lately and has been getting stretched out. His third and most-recent outing saw him toss 4 2/3 innings. But there’s not really a spot for him in the rotation, so the Yankees will seemingly put him in a long relief role. They also have Paul Blackburn doing long relief work and could cut him, though rosters expand in September, which will perhaps allow the club to roster both of them.

Photo courtesy of Jason Parkhurst, Imagn Images

Load More Posts

Show all

Headlines

Yankees Rumors

Navigation

MLBTR INFO

Connect